Abstract
MotivationVisualization is a powerful tool to analyze, understand and present big data. Computational biology, bioinformatics and molecular modeling require dedicated tools, tailored to very complex, highly multidimensional data. Over the recent years, numerous tools have been developed for online presentation, but new challenges like the COVID-19 pandemic require new libraries which will guarantee fast development of online tools for a better understanding of biomedical data/results.ResultsVisuaLife is a Python library that provides a new approach to visualization in a web browser. It offers 2D and 3D plotting capabilities as well as widgets designed to display the most common biological data types: nucleotide or protein sequences, 3D biomolecular structures and multiple sequence alignments. Components provided by the VisuaLife library can be assembled into a web application to create an analysis tool tailored to provide multidimensional analysis of a specific research problem. VisuaLife, to our best knowledge, is the most modern solution that allows one to implement such a client-side interactivity in Python.Availability and implementationThe git repository of the library is hosted at BitBucket: https://bitbucket.org/dgront/visualife/. PyPI distribution is also provided for MacOS and Linux. While basic examples are provided in the supporting materials, the full documentation is available at ReadTheDocs website: https://visualife.readthedocs.io/.Supplementary information Supplementary data are available at Bioinformatics online.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.